Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Psoriasis”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01484587
What this trial is testing

The Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 24
Not applicableUnknownNCT06165887
What this trial is testing

The Relationship Between Moderate-to-severe Psoriasis and Sleep Disturbance

Who this might be right for
Moderate-to-severe Psoriasis
Shanghai Yueyang Integrated Medicine Hospital 156
Early research (Phase 1)Study completedNCT03058744
What this trial is testing

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 94
Post-approval studies (Phase 4)Looking for participantsNCT03987763
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 45
Large-scale testing (Phase 3)Looking for participantsNCT07511647
What this trial is testing

Clinical Study of QL2106 Injection

Who this might be right for
Plaque Psoriasis
Qilu Pharmaceutical Co., Ltd. 318
Post-approval studies (Phase 4)Study completedNCT03331835
What this trial is testing

A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 210
Post-approval studies (Phase 4)Study completedNCT00581555
What this trial is testing

Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy

Who this might be right for
Psoriasis
Pfizer 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06143878
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 774
Post-approval studies (Phase 4)Study completedNCT02752776
What this trial is testing

Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 1,660
Testing effectiveness (Phase 2)Looking for participantsNCT07449702
What this trial is testing

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 240
Large-scale testing (Phase 3)Study completedNCT02718898
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis

Who this might be right for
Genital PsoriasisPsoriasis
Eli Lilly and Company 149
Not applicableUnknownNCT04912401
What this trial is testing

The Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis

Who this might be right for
PsoriasisEtanercept
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Post-approval studies (Phase 4)Study completedNCT04571567
What this trial is testing

Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Saakshi Khattri 20
Testing effectiveness (Phase 2)Study completedNCT04999839
What this trial is testing

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Takeda 259
Testing effectiveness (Phase 2)Study completedNCT04718896
What this trial is testing

Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 41
Not applicableWithdrawnNCT01758705
What this trial is testing

Post Marketing Observational Study on Venezuelan Patients With Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbbVie (prior sponsor, Abbott)
Testing effectiveness (Phase 2)Study completedNCT05003531
What this trial is testing

Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 250
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Large-scale testing (Phase 3)Study completedNCT00115076
What this trial is testing

Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Rockefeller University 31
Large-scale testing (Phase 3)Study completedNCT00235820
What this trial is testing

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 271
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation